España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Sandoz Group
SDZNY
OTCQX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$47.77
0.02
0.03%
At close: -
$47.20
-0.57
-1.19%
After Hours: Jan 28, 9:29 AM EDT
Get Report
Comment
Sandoz Group (SDZNY) Forecast
News
Earnings
Sandoz Group (SDZNY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Sandoz Group (OTC:SDZNY) Stock
Sandoz Group Stock (OTC: SDZNY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 22, 2025
FDA Adds Boxed Warning About Anaphylaxis With...
Benzinga Newsdesk
Tuesday, January 14, 2025
Reported Earlier, Sandoz Highlights Ambitious...
Benzinga Newsdesk
Tuesday, December 17, 2024
Sandoz Takes Major Steps Toward Legacy Antitr...
Benzinga Newsdesk
Tuesday, December 03, 2024
Why Is Coherus BioSciences Stock Trading Higher On Tuesday?
Vandana Singh
Friday, November 15, 2024
Sandoz Gains European Commission Approval For...
Benzinga Newsdesk
Wednesday, October 30, 2024
Sandoz Raised Its 2024 Net Sales Growth Guida...
Benzinga Newsdesk
Sandoz Q3 Sales $2.595B Up From $2.337B YoY
Benzinga Newsdesk
Friday, October 11, 2024
Sandoz Expands U.S. Oncology Portfolio With F...
Benzinga Newsdesk
Wednesday, September 11, 2024
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
Vandana Singh
Monday, August 12, 2024
Sandoz Secures FDA Approval For Enzeevu, Bols...
Benzinga Newsdesk
Thursday, July 25, 2024
Sandoz Strengthens Market Presence With Launc...
Benzinga Newsdesk
Wednesday, May 22, 2024
Sandoz Obtains European Commission Approval F...
Benzinga Newsdesk
Tuesday, May 07, 2024
Sandoz Q1 Sales $2.492B Up From $2.384B YoY
Benzinga Newsdesk
Tuesday, April 30, 2024
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
Vandana Singh
Sandoz And Amgen Resolve Patent Disputes Over...
Benzinga Newsdesk
Monday, April 22, 2024
Sandoz Gains European Commission Approval For...
Benzinga Newsdesk
Wednesday, March 13, 2024
Sandoz For 2024 Expects Net Sales To Grow Mid...
Benzinga Newsdesk
Sandoz Fiscal 2023 Core EPS $2.20 Down From $...
Benzinga Newsdesk
Friday, March 08, 2024
Beigene Said It Filed Patent Infringement Suits Against Sandoz, MSN Pharmaceuticals
Charles Gross
Tuesday, March 05, 2024
FDA Approves JUBBONTI By SANDOZ INC
Benzinga Newsdesk
Thursday, February 29, 2024
Generic/Biosimilar Player Sandoz Settles US Price Fixing Case For $265M
Vandana Singh
Wednesday, January 31, 2024
Sandoz Launches First And Only Biosimilar For...
Benzinga Newsdesk
Monday, January 22, 2024
Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today?
Vandana Singh
CORRECTION: Coherus To Divest Ophthalmology F...
Benzinga Newsdesk
Coherus To Divest Ophthalmology Franchise To ...
Benzinga Newsdesk
Monday, December 04, 2023
Venue Turmoil: Pharma Companies Oppose States' Bid to Relocate Price-Fixing Cases
Vandana Singh
Tuesday, November 28, 2023
Novartis Outlines Pure-Play Strategy Progress After Generics Business Spin-Off
Vandana Singh
Friday, November 10, 2023
Sandoz Inaugurates New Antibiotic Production ...
Benzinga Newsdesk
Tuesday, October 24, 2023
Novartis Q3: Earnings Beat, Raised Operating Profit Outlook & More
Lekha Gupta
Wednesday, October 04, 2023
Novartis Shares Decline As Spin Off Sandoz's Market Debut Falls Short of Expected Valuation
Vandana Singh
Novartis Earlier Announced it Completed The Spin-off Of Sandoz Unit; U.S. Sandoz ADRs To Trade Under Symbol 'SDZNY'
Charles Gross
